|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Masivet
|
|
Active substances:
|
|
|
ATC code:
|
QL01EX06
|
|
Dosage form:
|
film-coated tablet
|
|
Strength:
|
50mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Indication:
|
Treatment of non-resectable dog mast cell tumours (Grade 2 or 3) with confirmed mutated c-kit
tyrosine kinase receptor.
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
AB Science
|
|
Marketing authorization number:
|
EU/2/08/087
|
|
Marketing authorization issued on:
|
November 17, 2008
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1390777
|
Masivet
|
film-coated tablet
|
50mg 30TK
|
Prescription
|
|
|
16.03.2021
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere